Biocatalysis for pharmaceutical intermediates: the future is now
Top Cited Papers
- 1 February 2007
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 25 (2), 66-73
- https://doi.org/10.1016/j.tibtech.2006.12.005
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- IMPROVING EFFICIENCYChemical & Engineering News, 2006
- Immobilization of enzymes in microtiter plate scaleBiotechnology Journal, 2006
- Diversity and Biocatalytic Potential of Epoxide Hydrolases Identified by Genome AnalysisApplied and Environmental Microbiology, 2006
- Recombinant Chlorobenzene Dioxygenase from Pseudomonas sp. P51: A Biocatalyst for Regioselective Oxidation of Aromatic NitrilesAdvanced Synthesis & Catalysis, 2005
- New enzymes for biotransformationsCurrent Opinion in Chemical Biology, 2005
- In situ product removal using a crystallization loop in asymmetric reduction of 4‐oxoisophorone by Saccharomyces cerevisiaeBiotechnology & Bioengineering, 2004
- Recent developments in asymmetric reduction of ketones with biocatalystsTetrahedron: Asymmetry, 2003
- Efficient Synthesis of NK1 Receptor Antagonist Aprepitant Using a Crystallization-Induced Diastereoselective TransformationJournal of the American Chemical Society, 2003
- Towards a Large‐Scale Asymmetric Reduction Process with Isolated Enzymes: Expression of an (S)‐Alcohol Dehydrogenase in E. coli and Studies on the Synthetic Potential of this BiocatalystAdvanced Synthesis & Catalysis, 2003
- Enoate Reductases of ClostridiaPublished by Elsevier BV ,2001